- SEK42.40m
- SEK28.72m
- SEK54.22m
Brief: ScandiDos Gets Order For Delta4 Phantom+ MR
Brief: ScandiDos Gets First Order For Delta4 Phantom+ MR In Sweden
Brief: ScandiDos Gets FDA Approval For Delta4 Phantom+ MR
Brief: ScandiDos Proposes Rights Issue Of About SEK 34.5 Mln
Brief: ScandiDos Q3 EBITDA Loss Narrows To SEK 1.1 Mln
Brief: Scandidos And Radyalis Entered Cooperation
Brief: Scandidos Q2 EBITDA Loss Widens To SEK 5.3 Million
Brief: Scandidos Gets Order In Mexico
Brief: ScandiDos Q1 EBITDA Loss Widens To SEK 7.6 Mln
Brief: ScandiDos Q4 EBITDA Swings To Profit Of SEK 0.4 Million
Brief: ScandiDos Gets Order For SEK 1.7 Million From NKS
Brief: ScandiDos Q3 EBITDA Loss Widens To SEK 1.9 Million
Brief: ScandiDos Gets Orders Worth SEK 2.4 Million In USA
Brief: ScandiDos Gets Order From South Korea
Brief: ScandiDos Gets Order From University Of Utah, USA
Brief: ScandiDos Gets First Order In Texas
Brief: ScandiDos Q2 EBITDA Loss At SEK 2.3 Mln
Brief: ScandiDos Q1 EBITDA loss narrows to SEK 3.5 million
Brief: Scandidos sells to American hospital chain